Researcher
M.H.C. Bakkus
- Research Expertise:
Molecular diagnostics in Hemato-Oncology
Reference lab coördinator for molecular Ig/TCR MRD testing in acute lymphoblastic leukemia and multiple myeloma
- Keywords:Medicine, Pharmacy and pharmacology
- Disciplines:Natural sciences, Social sciences
- Users of research expertise:
Molecular diagnostics in Hemato-Oncology
Reference lab coördinator for molecular Ig/TCR MRD testing in acute lymphoblastic leukemia and multiple myeloma
Affiliations
- Clinical Biology (Department)
Member
From1 Jan 2016 → Today - Hematology (Research group)
Member
From1 Aug 1984 → Today - Basic (bio-) Medical Sciences (Department)
Member
From15 Nov 2023 → Today - Basic (bio-) Medical Sciences (Department)
Member
From15 Nov 2023 → 15 Nov 2023 - UZB Other (Department)
Member
From1 Jan 2008 → 31 Dec 2015 - Immunology and Microbiology (Department)
Member
From1 Jan 1999 → 14 Feb 2011 - Faculty of Medicine and Pharmacy (Faculty)
Member
From1 Jan 1992 → 30 Sep 1994
Publications
1 - 10 of 13
- Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pages: 599-611 - Lymphoma-like monoclonal B cell lymphocytosis in a patient population(2018)
Authors: Sam Vander Meeren, Bert Heyrman, Wim Renmans, M.H.C. Bakkus, Brigitte Maes, Hendrik De Raeve, Rik Schots, Kristin Jochmans
Pages: 1219-1227 - Intragenic amplification of PAX5(2017)
Authors: Claire Schwab, Karin Nebral, Lucy Chilton, Cristina Leschi, Esmé Waanders, Judith M Boer, Markéta Žaliová, Rosemary Sutton, Ingegerd Ivanov Öfverholm, Kentaro Ohki, et al.
Pages: 1473-1477 - A novel approach for BCR-ABL1 standardization to improve International Scale estimation(2016)
Authors: B Maes, M.H.C. Bakkus, N Boeckx, E Boone, B Cauwelier, B Denys, P De Schouwer, Tom Devos, H. El Housni, F. Hillen, et al.
Pages: 674-684 - Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia(2016)
Authors: Farzaneh Ghazavi, Barbara De Moerloose, Wouter Van Loocke, Annelynn Wallaert, Hetty Helsmoortel, Alina Ferster, M.H.C. Bakkus, Geneviève Plat, Eric Delabesse, Anne Uyttebroeck, et al.
Pages: 73769-73780 - IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy(2015)
Authors: Emmanuelle Clappier, Nathalie Grardel, M.H.C. Bakkus, Jerome Rapion, B. De Moerloose, P Kastner, Aurélie Caye, J Vivent, V. Costa, A. Ferster, et al.
Pages: 2154-2161 - CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol(2015)
Authors: Farzaneh Ghazavi, Emmanuelle Clappier, Tim Lammens, Stefan Suciu, Aurélie Caye, Samira Zegrari, M.H.C. Bakkus, Nathalie Grardel, Yves Benoit, Yves Bertrand, et al.
Pages: 1311-1319 - Minimal residual disease quantification by PCR in childhood acute lymphoblastic leukaemia.(2014)
Authors: Jona Van der Straeten, B. De Moerloose, Marie-Françoise Dresse, M-F Dresse, s dupont, ferster, p philippet, Anne Uyttebroek, Jutte van der Werff Ten Bosch, Christian Demanet, et al.
Pages: 81-88a - An intragenic ERG deletion (ERGdel) is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions(2014)
Authors: Emmanuelle Clappier, Marie-Françoise Auclerc, Jerome Rapion, M.H.C. Bakkus, Aurélie Caye, Ahlène Khemiri, Christine Giroux, Lucie Hernandez, Emmanuelle Kabongo, Suvi Savola, et al.
Pages: 70-77 - Reflections and proposals to assure quality in molecular diagnostics.(2011)
Authors: Marijke Raymaekers, M.H.C. Bakkus, E Boone, B. De Rijke, H. El Housni, P. Descheemaeker, P Deschouwer, S. Franke, F. Hillen, Friedel Nollet, et al.
Pages: 33-41